title: Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primates.
abstract: Although vesicular stomatitis virus (VSV) neurovirulence and pathogenicity in rodents have been well studied, little is known about VSV pathogenicity in non-human primates. To address this question, we measured VSV viremia, shedding, and neurovirulence in macaques. Following intranasal inoculation, macaques shed minimal recombinant VSV (rVSV) in nasal washes for 1 day post-inoculation; viremia was not detected. Following intranasal inoculation of macaques, wild type (wt) VSV, rVSV, and two rVSV-HIV vectors showed no evidence of spread to CNS tissues. However, macaques inoculated intrathalamically with wt VSV developed severe neurological disease. One of four macaques receiving rVSV developed clinical and histological signs similar to the wt group, while the remaining three macaques in this group and all of the macaques in the rVSV-HIV vector groups showed no clinical signs of disease and reduced severity of histopathology compared to the wt group. The implications of these findings for rVSV vaccine development are discussed.
authors.affiliation: Wyeth Vaccines Research, 401 N. Middletown Road, Pearl River, NY 10965, USA. johnsoe1@wyeth.com
authors.forename: J Erik
authors.initials: JE
authors.lastname: Johnson
authors.forename: Farooq
authors.initials: F
authors.lastname: Nasar
authors.forename: John W
authors.initials: JW
authors.lastname: Coleman
authors.forename: Roger E
authors.initials: RE
authors.lastname: Price
authors.forename: Ali
authors.initials: A
authors.lastname: Javadian
authors.forename: Kenneth
authors.initials: K
authors.lastname: Draper
authors.forename: Margaret
authors.initials: M
authors.lastname: Lee
authors.forename: Patricia A
authors.initials: PA
authors.lastname: Reilly
authors.forename: David K
authors.initials: DK
authors.lastname: Clarke
authors.forename: R Michael
authors.initials: RM
authors.lastname: Hendry
authors.forename: Stephen A
authors.initials: SA
authors.lastname: Udem
mesh_terms: D016915:AIDS Vaccines / Q000008:administration & dosage / Q000235:genetics; D000818:Animals; D001921:Brain / Q000473:pathology / Q000821:virology; D002493:Central Nervous System Diseases / Q000473:pathology / Q000821:virology*; D005822:Genetic Vectors / Q000008:administration & dosage / Q000502:physiology; D007249:Inflammation / Q000473:pathology; D008253:Macaca mulatta; D008297:Male; D008992:Monkey Diseases / Q000473:pathology / Q000821:virology*; D009297:Nasal Mucosa / Q000821:virology; D011995:Recombination, Genetic; D018353:Rhabdoviridae Infections / Q000473:pathology / Q000821:virology*; D013116:Spinal Cord / Q000473:pathology; D014721:Vesicular stomatitis Indiana virus / Q000472:pathogenicity / Q000502:physiology; D014766:Viremia; D014774:Virulence; D014779:Virus Replication
chemical_list: D016915:AIDS Vaccines